Logo

Freenome

Freenome, Walgreens Partner to Diversify Cancer Early Detection Studies

The pharmacy firm will lend its recruitment technology and infrastructure to enroll a more diverse patient population, beginning with Freenome's Sanderson Study.

In Brief This Week: Mainz Biomed, Centogene, DermTech, Freenome, Theradiag, More

News items for the week of April 10, 2023.

In Brief This Week: SQI Diagnostics, Chembio, Accelerate, Seegene, Freenome, More

News items for the week of March 27, 2023.

Freenome Partners With Geisinger to Recruit Patients for Multi-Cancer Screening Study

The Pennsylvania health system will be able to access patients in both urban and rural settings, aiding Freenome's goal to recruit a total of 8,000 individuals.

Freenome Launches Multi-Cancer Detection Study Using Multiomics, Real-World Evidence

The company plans to analyze both traditional and real-world data from about 8,000 individuals to validate and optimize its multi-cancer early detection platform.